CMS Doubts Power Of Purse To Stem Public Health Crises With Compounded Drugs

 

By Sue Sutter / Email the Author / View Full Issue
Reimbursement / Word Count: 1193 / Article # 00140505010 / Posted: May 5 2014 12:00 AM

---

Executive Summary

Medicare agency disagrees with HHS Office of Inspector General recommendation that providers be required to identify the source of compounded drugs submitted for Part B payment.

---

Purchase this Article

$50.00   Buy Now

---

For $50.00, purchase this 1193-word article and receive immediate online access. 100% Satisfaction Guarantee.
View a complete sample article »

Already a Subscriber?

Log in for complete access.

Log In

---

Questions?

Call Toll-Free (800) 332-2181 or +1 (908) 748-1221.

---